DVAX Annual SG&A
$152.95 M
+$21.54 M+16.39%
31 December 2023
Summary:
As of January 21, 2025, DVAX annual selling, general & administrative expenses is $152.95 million, with the most recent change of +$21.54 million (+16.39%) on December 31, 2023. During the last 3 years, it has risen by +$73.69 million (+92.98%). DVAX annual SG&A is now at all-time high.DVAX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DVAX Quarterly SG&A
$43.06 M
+$1.40 M+3.36%
30 September 2024
Summary:
As of January 21, 2025, DVAX quarterly selling, general & administrative expenses is $43.06 million, with the most recent change of +$1.40 million (+3.36%) on September 30, 2024. Over the past year, it has increased by +$5.01 million (+13.16%). DVAX quarterly SG&A is now -2.28% below its all-time high of $44.06 million, reached on March 31, 2024.DVAX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DVAX TTM SG&A
-$3.71 B
+$20.48 M+0.55%
30 September 2024
Summary:
As of January 21, 2025, DVAX TTM selling, general & administrative expenses is -$3.71 billion, with the most recent change of +$20.48 million (+0.55%) on September 30, 2024. Over the past year, it has dropped by -$3.85 billion (-2698.88%). DVAX TTM SG&A is now -4572.25% below its all-time high of $170.07 million, reached on September 30, 2024.DVAX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DVAX Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +16.4% | +13.2% | -2698.9% |
3 y3 years | +93.0% | +59.9% | -4277.2% |
5 y5 years | +136.1% | +133.3% | -5045.1% |
DVAX Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +52.7% | -2.3% | +47.4% | at high | +27.5% |
5 y | 5-year | at high | +104.0% | -2.3% | +141.4% | at high | +28.6% |
alltime | all time | at high | +4331.9% | -2.3% | +2143.9% | -4572.3% | +28.6% |
Dynavax Technologies Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $43.06 M(+3.4%) | $170.07 M(+3.0%) |
June 2024 | - | $41.66 M(-5.5%) | $165.06 M(+2.9%) |
Mar 2024 | - | $44.06 M(+6.7%) | $160.47 M(+4.9%) |
Dec 2023 | $152.95 M(+16.4%) | $41.28 M(+8.5%) | $152.95 M(+7.2%) |
Sept 2023 | - | $38.05 M(+2.6%) | $142.68 M(+4.4%) |
June 2023 | - | $37.07 M(+1.4%) | $136.67 M(+0.7%) |
Mar 2023 | - | $36.54 M(+17.8%) | $135.78 M(+3.3%) |
Dec 2022 | $131.41 M(+31.2%) | $31.02 M(-3.2%) | $131.41 M(+1.4%) |
Sept 2022 | - | $32.04 M(-11.4%) | $129.62 M(+4.1%) |
June 2022 | - | $36.18 M(+12.5%) | $124.50 M(+13.3%) |
Mar 2022 | - | $32.17 M(+10.1%) | $109.91 M(+9.7%) |
Dec 2021 | $100.16 M(+26.4%) | $29.22 M(+8.5%) | $100.16 M(+12.8%) |
Sept 2021 | - | $26.93 M(+24.8%) | $88.77 M(+6.5%) |
June 2021 | - | $21.58 M(-3.7%) | $83.38 M(+3.3%) |
Mar 2021 | - | $22.42 M(+25.7%) | $80.75 M(+1.9%) |
Dec 2020 | $79.26 M(+5.7%) | $17.84 M(-17.2%) | $79.26 M(-3.0%) |
Sept 2020 | - | $21.54 M(+13.6%) | $81.74 M(+3.9%) |
June 2020 | - | $18.95 M(-9.4%) | $78.66 M(+1.4%) |
Mar 2020 | - | $20.93 M(+3.0%) | $77.56 M(+3.4%) |
Dec 2019 | $74.99 M(+15.8%) | $20.32 M(+10.1%) | $74.99 M(+5.5%) |
Sept 2019 | - | $18.46 M(+3.3%) | $71.11 M(+3.9%) |
June 2019 | - | $17.86 M(-2.7%) | $68.44 M(+3.3%) |
Mar 2019 | - | $18.35 M(+11.6%) | $66.23 M(+2.2%) |
Dec 2018 | $64.77 M(+136.7%) | $16.44 M(+4.1%) | $64.77 M(+12.5%) |
Sept 2018 | - | $15.79 M(+0.9%) | $57.59 M(+20.4%) |
June 2018 | - | $15.65 M(-7.3%) | $47.83 M(+26.6%) |
Mar 2018 | - | $16.89 M(+82.5%) | $37.79 M(+38.1%) |
Dec 2017 | $27.37 M(-26.5%) | $9.26 M(+53.6%) | $27.37 M(+4.1%) |
Sept 2017 | - | $6.03 M(+7.4%) | $26.28 M(-17.9%) |
June 2017 | - | $5.61 M(-13.3%) | $32.02 M(-10.0%) |
Mar 2017 | - | $6.47 M(-20.8%) | $35.56 M(-4.6%) |
Dec 2016 | $37.26 M(+68.0%) | $8.17 M(-30.6%) | $37.26 M(+4.1%) |
Sept 2016 | - | $11.77 M(+28.6%) | $35.78 M(+21.1%) |
June 2016 | - | $9.15 M(+12.0%) | $29.54 M(+15.9%) |
Mar 2016 | - | $8.17 M(+21.9%) | $25.49 M(+14.9%) |
Dec 2015 | $22.18 M(+24.9%) | $6.70 M(+21.3%) | $22.18 M(+8.0%) |
Sept 2015 | - | $5.52 M(+8.4%) | $20.53 M(+6.8%) |
June 2015 | - | $5.10 M(+4.9%) | $19.22 M(+4.5%) |
Mar 2015 | - | $4.86 M(-3.8%) | $18.39 M(+3.5%) |
Dec 2014 | $17.76 M(-33.9%) | $5.05 M(+19.9%) | $17.76 M(+8.2%) |
Sept 2014 | - | $4.21 M(-1.1%) | $16.42 M(-13.3%) |
June 2014 | - | $4.26 M(+0.7%) | $18.93 M(-15.1%) |
Mar 2014 | - | $4.23 M(+14.2%) | $22.30 M(-17.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2013 | $26.87 M(-4.6%) | $3.71 M(-44.9%) | $26.87 M(-17.2%) |
Sept 2013 | - | $6.72 M(-11.9%) | $32.45 M(-1.2%) |
June 2013 | - | $7.64 M(-13.2%) | $32.85 M(+5.4%) |
Mar 2013 | - | $8.80 M(-5.3%) | $31.17 M(+10.7%) |
Dec 2012 | $28.16 M(+60.3%) | $9.29 M(+30.5%) | $28.16 M(+20.3%) |
Sept 2012 | - | $7.12 M(+19.5%) | $23.42 M(+14.2%) |
June 2012 | - | $5.96 M(+2.8%) | $20.51 M(+10.2%) |
Mar 2012 | - | $5.79 M(+27.5%) | $18.61 M(+5.9%) |
Dec 2011 | $17.57 M(+4.1%) | $4.54 M(+7.8%) | $17.57 M(+2.1%) |
Sept 2011 | - | $4.22 M(+4.0%) | $17.21 M(+1.6%) |
June 2011 | - | $4.05 M(-14.7%) | $16.94 M(-0.7%) |
Mar 2011 | - | $4.75 M(+13.6%) | $17.06 M(+1.1%) |
Dec 2010 | $16.88 M(+7.2%) | $4.18 M(+5.9%) | $16.88 M(+0.8%) |
Sept 2010 | - | $3.95 M(-5.3%) | $16.75 M(+1.3%) |
June 2010 | - | $4.17 M(-8.7%) | $16.53 M(+4.0%) |
Mar 2010 | - | $4.57 M(+12.8%) | $15.89 M(+0.9%) |
Dec 2009 | $15.74 M(+1.8%) | $4.05 M(+8.5%) | $15.74 M(+3.2%) |
Sept 2009 | - | $3.74 M(+5.7%) | $15.25 M(-1.1%) |
June 2009 | - | $3.53 M(-20.1%) | $15.43 M(+0.7%) |
Mar 2009 | - | $4.42 M(+24.3%) | $15.32 M(-1.0%) |
Dec 2008 | $15.46 M(-15.5%) | $3.56 M(-9.0%) | $15.46 M(-7.9%) |
Sept 2008 | - | $3.91 M(+14.4%) | $16.78 M(-6.2%) |
June 2008 | - | $3.42 M(-25.2%) | $17.90 M(-4.2%) |
Mar 2008 | - | $4.57 M(-6.3%) | $18.68 M(+2.1%) |
Dec 2007 | $18.29 M(+23.3%) | $4.88 M(-3.0%) | $18.29 M(+3.9%) |
Sept 2007 | - | $5.03 M(+19.6%) | $17.61 M(+2.2%) |
June 2007 | - | $4.21 M(+0.6%) | $17.24 M(+5.0%) |
Mar 2007 | - | $4.18 M(-0.4%) | $16.41 M(+10.6%) |
Dec 2006 | $14.84 M(+60.3%) | $4.20 M(-9.9%) | $14.84 M(+16.2%) |
Sept 2006 | - | $4.66 M(+37.8%) | $12.77 M(+22.4%) |
June 2006 | - | $3.38 M(+29.9%) | $10.43 M(+9.5%) |
Mar 2006 | - | $2.60 M(+22.4%) | $9.52 M(+2.8%) |
Dec 2005 | $9.26 M(+8.4%) | $2.13 M(-8.3%) | $9.26 M(-4.2%) |
Sept 2005 | - | $2.32 M(-6.2%) | $9.66 M(+3.2%) |
June 2005 | - | $2.47 M(+5.7%) | $9.36 M(+4.4%) |
Mar 2005 | - | $2.34 M(-7.5%) | $8.96 M(+4.9%) |
Dec 2004 | $8.54 M(+103.0%) | $2.53 M(+25.4%) | $8.54 M(+42.1%) |
Sept 2004 | - | $2.02 M(-2.9%) | $6.01 M(+50.5%) |
June 2004 | - | $2.08 M(+8.2%) | $4.00 M(+108.2%) |
Mar 2004 | - | $1.92 M | $1.92 M |
Dec 2003 | $4.21 M(+2.1%) | - | - |
Dec 2002 | $4.12 M(-9.0%) | - | - |
Dec 2001 | $4.53 M(+31.2%) | - | - |
Dec 2000 | $3.45 M | - | - |
FAQ
- What is Dynavax Technologies annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Dynavax Technologies?
- What is Dynavax Technologies annual SG&A year-on-year change?
- What is Dynavax Technologies quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Dynavax Technologies?
- What is Dynavax Technologies quarterly SG&A year-on-year change?
- What is Dynavax Technologies TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Dynavax Technologies?
- What is Dynavax Technologies TTM SG&A year-on-year change?
What is Dynavax Technologies annual selling, general & administrative expenses?
The current annual SG&A of DVAX is $152.95 M
What is the all time high annual SG&A for Dynavax Technologies?
Dynavax Technologies all-time high annual selling, general & administrative expenses is $152.95 M
What is Dynavax Technologies annual SG&A year-on-year change?
Over the past year, DVAX annual selling, general & administrative expenses has changed by +$21.54 M (+16.39%)
What is Dynavax Technologies quarterly selling, general & administrative expenses?
The current quarterly SG&A of DVAX is $43.06 M
What is the all time high quarterly SG&A for Dynavax Technologies?
Dynavax Technologies all-time high quarterly selling, general & administrative expenses is $44.06 M
What is Dynavax Technologies quarterly SG&A year-on-year change?
Over the past year, DVAX quarterly selling, general & administrative expenses has changed by +$5.01 M (+13.16%)
What is Dynavax Technologies TTM selling, general & administrative expenses?
The current TTM SG&A of DVAX is -$3.71 B
What is the all time high TTM SG&A for Dynavax Technologies?
Dynavax Technologies all-time high TTM selling, general & administrative expenses is $170.07 M
What is Dynavax Technologies TTM SG&A year-on-year change?
Over the past year, DVAX TTM selling, general & administrative expenses has changed by -$3.85 B (-2698.88%)